U.S. markets open in 6 hours 23 minutes

Genomma Lab Internacional, S.A.B. de C.V. (LABB.MX)

Mexico - Mexico Delayed Price. Currency in MXN
Add to watchlist
21.24+0.42 (+2.02%)
At close: 02:59PM CDT
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close20.82
Bid0.00 x 50000
Ask0.00 x 194200
Day's Range0.00 - 0.00
52 Week Range
Avg. Volume1,967,117
Market Cap21.828B
Beta (5Y Monthly)0.48
PE Ratio (TTM)14.55
EPS (TTM)1.46
Earnings DateJul 20, 2021 - Jul 26, 2021
Forward Dividend & Yield0.38 (1.92%)
Ex-Dividend DateJun 06, 2022
1y Target Est24.39
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for LABB.MX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • PR Newswire


      Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence, informs that the Company filed a Notice of Rights with the Mexican Stock Exchange (Bolsa Mexicana de Valores) declaring a cash dividend on its common stock of $ 0.381679389 Mexican pesos per share, or a total amount of $ 400,000,000.00 M.N. (four hundred million pesos 00/100 National Curre

    • PR Newswire

      Genomma Lab Internacional Reports First Quarter 2022 Results

      Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma Lab" or "the Company"), today announced its results for the first quarter ended March 31, 2022. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with International Financial Reporting Standards (IFRS).

    • PR Newswire

      Genomma Lab Announces First Quarter 2022 Financial Results Call and Webcast

      Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) ("Genomma Lab" or "the Company"), today announced that it will report its First Quarter 2022 results on Wednesday, April 27, 2022 after the Mexican Market (BMV) close. The company also announced that it will hold a conference call on April 28, 2022 at 11 a.m. ET to discuss its quarterly financial results.